View the latest Bayer AG (BAYN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Bayer has its first regulatory approval for elinzanetant as a non-hormonal treatment for menopausal symptoms – in the UK – as it chases down a rival therapy from Astellas.